Our top pick for
Chewy, Inc is an internet retail business based in the US. Chewy shares (CHWY) are listed on the NYSE and all prices are listed in US Dollars. Chewy employs 12,000 staff and has a trailing 12-month revenue of around USD$6.5 billion.
|52-week range||USD$20.62 - USD$119.63|
|50-day moving average||USD$106.8347|
|200-day moving average||USD$78.7618|
|Wall St. target price||USD$101.42|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$-0.646|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|Revenue TTM||USD$6.5 billion|
|Gross profit TTM||USD$1.1 billion|
|Return on assets TTM||-8.63%|
|Return on equity TTM||0%|
|Market capitalisation||USD$39 billion|
TTM: trailing 12 months
There are currently 10.4 million Chewy shares held short by investors – that's known as Chewy's "short interest". This figure is 23.9% down from 13.7 million last month.
There are a few different ways that this level of interest in shorting Chewy shares can be evaluated.
Chewy's "short interest ratio" (SIR) is the quantity of Chewy shares currently shorted divided by the average quantity of Chewy shares traded daily (recently around 3.0 million). Chewy's SIR currently stands at 3.51. In other words for every 100,000 Chewy shares traded daily on the market, roughly 3510 shares are currently held short.
However Chewy's short interest can also be evaluated against the total number of Chewy shares, or, against the total number of tradable Chewy shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Chewy's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Chewy shares in existence, roughly 30 shares are currently held short) or 0.161% of the tradable shares (for every 100,000 tradable Chewy shares, roughly 161 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Chewy.
Find out more about how you can short Chewy stock.
We're not expecting Chewy to pay a dividend over the next 12 months.
Chewy, Inc., together with its subsidiaries, engages in the pure-play e-commerce business in the United States. The company provides pet food and treats, pet supplies and pet medications, and other pet-health products, as well as pet services for dogs, cats, fish, birds, small pets, horses, and reptiles through its chewy.com retail Website, as well as its mobile applications. It offers approximately 60,000 products from 2,000 partner brands. The company was founded in 2010 and is headquartered in Dania Beach, Florida. Chewy, Inc. is a subsidiary of PetSmart, Inc.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
Everything we know about the SEMrush Holdings Inc IPO, plus information on how to buy in.
Everything we know about the ChargePoint IPO, plus information on how to buy in.
Everything we know about the Kaltura Inc IPO, plus information on how to buy in.
Everything we know about the Rocket Lab IPO, plus information on how to buy in.
Everything we know about the Soho House IPO, plus information on how to buy in.
Everything we know about the VIZIO IPO, plus information on how to buy in.
Everything we know about the IDW Media Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Karooooo Ltd IPO, plus information on how to buy in.
Everything we know about the Connect Biopharma Holdings Limited IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.